Aberdeen Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Sell
1,031,059
-166,563
-14% -$1.94M 0.02% 553
2025
Q1
$8.9M Buy
1,197,622
+193,563
+19% +$1.44M 0.02% 587
2024
Q4
$6.02M Sell
1,004,059
-25,388
-2% -$152K 0.01% 617
2024
Q3
$5.27M Hold
1,029,447
0.01% 639
2024
Q2
$3.73M Hold
1,029,447
0.01% 681
2024
Q1
$3.3M Buy
1,029,447
+95,653
+10% +$307K 0.01% 728
2023
Q4
$4.58M Buy
+933,794
New +$4.58M 0.01% 684